Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.

Background: Identification of urinary biomarkers for detection of bladder cancer recurrence would be beneficial to minimize the frequency of cystoscopy. Our objective was to determine the usability of urine content of mRNA in the detection and prediction of bladder cancer recurrence.Methods: We anal...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Cancer Vol. 10; pp. 646 - 647
Autores principales: Brems-Eskildsen, Anne Sofie, Zieger, Karsten, Toldbod, Helle, Holcomb, Cherie, Higuchi, Russell, Mansilla, Francisco, Munksgaard, Pia P, Borre, Michael, ørntoft, Torben F, Dyrskjøt, Lars, Ørntoft, Torben F
Formato: research Journal Article
Publicado: BioMed Central 2010
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104993960&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104993960
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14712407
        1CH9
      jtl: BMC Cancer
      issn: 14712407
      maglogo: N
    pubinfo:
      dt: 2010
      vid: 10
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        104993960
        NLM21106093
        2010916451
        10.1186/1471-2407-10-646
        NLM21106093
        PMC3001447
        104993960
      ppf: 646
      ppct: 1
      formats:
      tig:
        atl: Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
      aug:
        au:
          Brems-Eskildsen, Anne Sofie
          Zieger, Karsten
          Toldbod, Helle
          Holcomb, Cherie
          Higuchi, Russell
          Mansilla, Francisco
          Munksgaard, Pia P
          Borre, Michael
          ørntoft, Torben F
          Dyrskjøt, Lars
          Ørntoft, Torben F
        affil: Department of Molecular Medicine, Aarhus University Hospital, Skejby, Denmark.
      sug:
        subj:
          Cell Cycle Proteins
          Peptide Hydrolases
          Neoplasm Recurrence, Local
          Esterases
          RNA Urine
          Transferases
          Tumor Markers, Biological
          Bladder Neoplasms Diagnosis
          Aged
          Biopsy
          Cross Sectional Studies
          Cystoscopy
          Denmark
          Female
          Human
          Male
          Neoplasm Staging
          Predictive Value of Tests
          Prognosis
          Prospective Studies
          Reverse Transcriptase Polymerase Chain Reaction
          Sensitivity and Specificity
          Time Factors
          Bladder Neoplasms
          Bladder Neoplasms Pathology
          Bladder Neoplasms Urine
          Aged: 65+ years
          Female
          Male
      ab: Background: Identification of urinary biomarkers for detection of bladder cancer recurrence would be beneficial to minimize the frequency of cystoscopy. Our objective was to determine the usability of urine content of mRNA in the detection and prediction of bladder cancer recurrence.Methods: We analyzed 123 prospectively cross-sectional collected urine samples from 117 patients with bladder cancer (12 incident cancers and 111 control visits). We used biopsies from cystoscopies as diagnostic criteria for recurrence, and followed the patients for a median time of 28.5 months (range 0-44 months). We measured the levels of hTERT, SENP1, PPP1CA, and MCM5 mRNA in urine by q-RT- PCR.Results: We found significant differences in urinary content of hTERT (p < 0.001), SENP1 (p < 0.001), MCM5 (p < 0.001), and PPP1CA (p < 0.001) transcripts, when comparing urine samples from patients with and without tumor present in the bladder. We obtained sensitivity and specificity values for hTERT: 63/73, SENP1: 56/78, MCM5: 63/66, and PPP1CA: 69/63, respectively. Including follow-up data resulted in sensitivity and specificity values for hTERT: 62/84, SENP1:53/84, MCM5: 61/73, and PPP1CA: 65/66. Interestingly, at non-tumor visits the urinary content of especially hTERT (p = 0.0001) and MCM5 (p = 0.02) were significantly associated with subsequent tumour recurrence. Combining the markers with cytology improved the detection. The best combination was hTERT and cytology with a sensitivity of 71% and a specificity of 86% after follow-up. Further prospective validation or registration studies needs to be carried out before clinical use.Conclusions: We could use the urinary content of hTERT, SENP1, PPP1CA, and MCM5 to detect bladder cancer recurrence. All markers showed a higher sensitivity than cytology. The detection rate improved when including cytology results, but also the combination of hTERT and MCM5 increased the detection rate. Furthermore, hTERT and MCM5 levels predicted subsequent tumor recurrences.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N